Answers are grounded in this paper and cite their sources.
Vaccination is cost-beneficial in most influenza seasons in healthy working adults. Although the benefits of antiviral therapy for persons with influenza infection appear to justify its cost, head-to-head trials of the various antiviral therapies are needed to determine the optimal treatment strategy.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: